DV
Dividend Vision

BVS — Bioventus Inc

Bioventus Inc (BVS)

Total return is -25.8% over the past 5.5 years, 139.8 points behind SPY at 114.0%. Its deepest 1-year drawdown was 27.5%.

Bioventus Inc. is a medical device company that develops and sells pain relief and musculoskeletal therapy products, including intra-articular injections for knee osteoarthritis, peripheral nerve stimulation devices, ultrasonic surgical systems, bone graft substitutes, and fracture treatment solutions to healthcare institutions, physicians, and patients. The company does not currently distribute dividends. Bioventus appeals to investors seeking equity exposure to the orthopedic and surgical medical device sector rather than current income.

BVS key facts

Asset type
Stock
Asset class
Equity
Inception date
02/11/2021
Last close
$14.26
Market cap
$817,041,472
Average volume
506038.0
Beta
0.653
Payout ratio
0.0
P/E ratio
29.4146
Forward P/E
15.3846
EPS
$0.41